Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.

Batra, Anupam; Ernst, Scott; Potvin, Kylea; Fernandes, Ricardo; Power, Nicholas; Vanhie, James; Winquist, Eric.

Afiliação

Batra A; Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
Ernst S; Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
Potvin K; Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
Fernandes R; Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
Power N; Division of Urology, Department of Surgery, Western University and London Health Sciences Centre, London, ON, Canada.
Vanhie J; London Health Sciences Centre, London, ON, Canada.
Winquist E; Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.

Can Urol Assoc J ; 14(2): 43-47, 2020 Feb.

Article em En | MEDLINE | ID: mdl-31348750

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article